Follow institutional protocols or product labeling for guidance on maximum duration of use after opening (typically ranging from hours to days depending on clinical setting and protocol)
Only three pilot human studies have examined BPC-157, focusing on knee pain, interstitial cystitis, and intravenous safety rather than neuropathy specifically
No human clinical trials of 5-Amino-1MQ in obesity, sarcopenia, or any other indication have been published in peer-reviewed journals
Advanced Dermatological Research , 28(2), 8192
Cenexa Labs has no affiliation with Professor Muresanu or his institutions, and this information does not constitute an endorsement of any products or services
The comparison in this article is therefore assembled from separate bodies of evidence human topical cosmetic studies on one side, animal and mechanistic work on the other rather than from a single trial that pits the routes against each other